Vault-13

Foresite Capital Management V, LLC

WEST HOLLYWOOD, CA · CIK 1792206 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$362.2m reported value +33.7% vs Q1 2026
9positions
100.0%in top 10
1 new 2 added 1 reduced 1 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ALUMIS INC COM ALMS ALMS 5,896,995 $165.9m45.81% 45.81% UnchangedShares held: Q3 2025 5.8m, Q4 2025 5.8m, Q1 2026 5.9m, Q2 2026 5.9m
2 CG ONCOLOGY INC COM CGON CGON 1,079,050 $76.7m21.17% 21.17% AddedShares held: Q3 2025 1.0m, Q4 2025 1.0m, Q1 2026 1.0m, Q2 2026 1.1m +75.0k +75,000 7.5%
3 DISC MEDICINE INC COM IRON IRON 374,069 $27.4m7.55% 7.55% UnchangedShares held: Q3 2025 299.1k, Q4 2025 299.1k, Q1 2026 374.1k, Q2 2026 374.1k
4 HIMS & HERS HEALTH INC COM CL A HIMS HIMS 738,151 $25.6m7.07% 7.07% UnchangedShares held: Q3 2025 273.2k, Q4 2025 273.2k, Q1 2026 738.2k, Q2 2026 738.2k
5 PHARVARIS N V COM PHVS PHVS 664,142 $23.0m6.34% 6.34% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 194.1k, Q2 2026 664.1k +470.0k +470,017 242.1%
6 EIKON THERAPEUTICS INC COM EIKN EIKN 1,318,983 $17.2m4.75% 4.75% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.3m, Q2 2026 1.3m
7 ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX ODTX 713,105 $13.3m3.68% 3.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 713.1k
8 LYELL IMMUNOPHARMA INC COM NEW LYEL LYEL 476,386 $6.7m1.85% 1.85% ReducedShares held: Q3 2025 477.1k, Q4 2025 477.1k, Q1 2026 477.1k, Q2 2026 476.4k -692 -692 -0.1%
9 NURIX THERAPEUTICS INC COM NRIX NRIX 265,000 $6.4m1.77% 1.77% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 265.0k, Q2 2026 265.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
MAZE THERAPEUTICS INC MAZE MAZE 25,905 $773.3k25.9k shares